Cancer Nanotechnology Specialists apply cutting-edge nanotechnology to revolutionize cancer diagnosis, treatment, and prevention. Nanotechnology involves manipulating materials at the nanoscale, creating particles that can interact with biological systems in highly precise ways. These specialists design nanoparticles capable of delivering chemotherapy, gene therapy, or other therapeutic agents directly to cancer cells, ensuring a more targeted treatment approach. By focusing treatment specifically on tumor cells, this technology minimizes damage to surrounding healthy tissues, enhancing treatment efficacy while reducing harmful side effects, thus offering a more personalized and effective method for cancer management.
Cancer nanotechnology specialists are developing nanoscale imaging techniques that allow for earlier and more accurate detection of cancers. These innovations improve the ability to identify tumors at their earliest stages, leading to more timely interventions. Nanotechnology is also being explored for cancer vaccines, where nanoscale materials help deliver immune-stimulating agents directly to immune cells, promoting the body’s ability to fight cancer. Through ongoing advancements, cancer nanotechnology specialists are contributing to a new era in cancer care, providing groundbreaking tools and treatments that offer hope for better patient outcomes and long-term survival. They are also exploring the use of nanomaterials for overcoming drug resistance, a significant challenge in cancer treatment. By improving the solubility, stability, and delivery of drugs, these specialists aim to enhance the effectiveness of treatments that may otherwise be ineffective against resistant cancer types.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China